Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: A prospectively randomized trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN) - Atzpodien, J; Kirchner, H; Jonas, U (J Clin Oncol, 2004)
et al.